Clinical Trial

Prospective Registry of Acute Ischemic Stroke in Children Under 18 Years Old in China

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This observational study aims to investigate the real-world effectiveness and safety of different treatment strategies for acute ischemic stroke (AIS) in Chinese children under 18 years of age. Its primary research question is: In real-world clinical practice, does endovascular therapy (e.g., stent retriever thrombectomy, aspiration thrombectomy) improve 90-day functional outcomes in pediatric AIS patients with acute anterior or posterior circulation large vessel occlusion? Children under 18 years of age receiving routine AIS diagnosis and treatment at approximately 25-35 study centers across China will undergo neurological function assessments, imaging examinations, and evaluations of growth, development, and psychosocial status at baseline, 24 hours post-procedure, 7 days post-procedure or at hospital discharge, and at 90 days and 6 months post-onset. Adverse events will also be documented.
Trial Details
NCT Number NCT07550257
Lead Sponsor Gansu Provincial Maternal and Child Health Care Hospital
Conditions Acute Ischemic Stroke (AIS), Pediatric Stroke
Enrollment 1,000 participants
Start Date 2026-06-01
Primary Completion 2029-05-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-24